1. CHARACTERISTICS, TREATMENT, AND OUTCOMES OF ≥ 80 YEAR OLD PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) ENROLLED TO PROSPECTIVE TRIALS OF THE GERMAN CLL STUDY GROUP. (June 2017) Authors: Al‐Sawaf, O.; Bahlo, J.; Fischer, K.; Herling, C.; Bergmann, M.; Fink, A.M.; von Tresckow, J.; Langerbeins, P.; Cramer, P.; Stilgenbauer, S.; Wendtner, C.M.; Eichhorst, B.; Hallek, M.; Goede, V. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FIXED‐DURATION VENETOCLAX PLUS OBINUTUZUMAB IMPROVES PFS AND MINIMAL RESIDUAL DISEASE NEGATIVITY IN PATIENTS WITH PREVIOUSLY UNTREATED CLL AND COMORBIDITIES. (12th June 2019) Authors: Fischer, K.; Porro Lurà, M.; Al‐Sawaf, O.; Bahlo, J.; Fink, A.; Tandon, M.; Dixon, M.; Robrecht, S.; Warburton, S.; Humphrey, K.; Samoylova, O.; Liberati, A.M.; Pinilla‐Ibarz, J.; Opat, S.; Sivcheva, L.; Le Dû, K.; Fogliatto, L.M.; Utoft Niemann, C.; Weinkove, R.; Robinson, S. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P652: MEASURING MINIMAL RESIDUAL DISEASE BEYOND 10-4 THROUGH IGHV LEADER-BASED NEXT GENERATION SEQUENCING IMPROVES PROGNOSTIC STRATIFICATION IN CHRONIC LYMPHOCYTIC LEUKEMIA. (23rd June 2022) Authors: Hengeveld, P.; van der Klift, M.; Kolijn, P. M.; Davi, F.; Kavelaars, F.; de Jonge, E.; Robrecht, S.; Assmann, J.; van der Straten, L.; Ritgen, M.; Westerweel, P.; Fischer, K.; Goede, V.; Hallek, M.; Levin, M.-D.; Langerak, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 550 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗